Drugs / Gabapentin
Gabapentin
also known as
Neurontin · Gralise · G-ER · Gabapentine · GBP · Conventin · G-GR · gabapentin ER · +14 more
Regulatory milestones approvals, filings & regulatory actions · 4 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (3) | US (FDA) | NEURONTIN | — | 1998-09-29 – 2002-08-15 | fda.gov ↗ |
| Approved | US (FDA) | NEURONTIN | — | 1993-12-30 | fda.gov ↗ |
Trials 241 · started per year
today
US approved 1993
1
1
2
2
1
5
5
5
13
10
10
9
7
8
10
3
7
8
11
14
8
19
15
17
10
12
11
6
4
4
3
199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 08 trials | ||||||
| Phase 0 | NCT05533684 | Sep → Dec 2022 | neuropathy, painful | Minia University | Completed | No outcome recorded |
| Phase 0 | NCT04631510 | Dec 2020 → Aug 2023 | — | Tufts Medical Center | Completed | No outcome recorded |
| Phase 0 | NCT04620720 | Aug → Dec 2020 | — | Combined Military Hospital, Pakistan | Unknown | No outcome recorded |
| Phase 0 | NCT03820193 | Jan 2019 → Jun 2020 | substance-related disorder | Henry Ford Health System | Completed | No outcome recorded |
| Phase 0 | NCT03589898 | Sep 2017 → Aug 2022 | autism spectrum disorder | University of Massachusetts, Worcester | Completed | No outcome recorded |
| Phase 0 | NCT02856750 | Oct 2016 → Oct 2018 | — | Denver Health and Hospital Authority | Completed | No outcome recorded |
| Phase 0 | NCT03346668 | Jan 2016 → Oct 2021 | central centrifugal cicatricial alopecia, frontal fibrosing alopecia, lichen planopilaris | University of Minnesota | Completed | No outcome recorded |
| Phase 0 | NCT01441531 | Jan 2012 → Jun 2014 | — | Baylor College of Medicine | Withdrawn | No outcome recorded |
| Phase 115 trials | ||||||
| Phase 1 | NCT04658732 | Dec 2020 → Jun 2021 | — | Ehab Tarek Fahmy | Unknown | No outcome recorded |
| Phase 1 | NCT04315181 | Mar 2019 → May 2023 | substance-related disorder | Sharon Walsh | Completed | No outcome recorded |
| Phase 1 | NCT02531906 | Apr 2015 → Jun 2018 | head and neck squamous cell carcinoma, stomatitis | Roswell Park Cancer Institute | Completed | No outcome recorded |
| Phase 1 | NCT02056899 | Jun 2013 → Aug 2015 | — | State University of New York at Buffalo | Completed | No outcome recorded |
| Phase 1 | NCT01485185 | Oct 2011 → Jul 2012 | neuropathy, painful | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01421264 | Aug 2011 → Dec 2012 | insomnia | State University of New York at Buffalo | Completed | No outcome recorded |
| Phase 1 | NCT01092520 | Jul 2009 → Jul 2011 | — | The Hospital for Sick Children | Withdrawn | No outcome recorded |
| Phase 1 | NCT00733239 | Aug 2008 → Oct 2010 | opiate dependence | University of Arkansas | Completed | No outcome recorded |
| Phase 1 | NCT00593463 | Sep 2006 → May 2010 | drug dependence | University of Arkansas | Completed | No outcome recorded |
| Phase 1 | NCT00865059 | Feb 2001 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00865423 | Feb 2001 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00865631 | Jun 1999 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00864760 | Jun 1999 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00864058 | Jan 1998 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00864305 | Dec 1997 → Jan 1998 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT06705101 | Dec 2024 → Jun 2025 overdue | — | Liaquat National Hospital & Medical College | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT05664464 | Jan 2023 → Jun 2026 overdue | glioblastoma | University of Zurich | Recruiting | No outcome recorded |
| Phase 1/2 | NCT05156060 | Jan 2022 → Dec 2025 overdue | head and neck carcinoma | Natalie Lockney | Recruiting | No outcome recorded |
| Phase 1/2 | NCT02557945 | Aug 2015 → Jun 2016 | early-onset schizophrenia | New York State Psychiatric Institute | Terminated | No outcome recorded |
| Phase 235 trials | ||||||
| Phase 2 | NCT05064319 | Feb 2022 → Jul 2026 overdue | bipolar I disorder, bipolar II disorder, cannabis dependence, schizoaffective bipolar disorder | Medical University of South Carolina | Recruiting | No outcome recorded |
| Phase 2 | NCT05184192 | Jan 2022 → Aug 2023 | COVID-19, anosmia, olfactory nerve disorder | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT04766229 | Jun 2021 → Nov 2022 | cancer, insomnia | University College Dublin | Completed | No outcome recorded |
| Phase 2 | NCT04619862 | May 2021 → Mar 2026 | neuropathy, painful | University of British Columbia | Unknown | No outcome recorded |
| Phase 2 | NCT04429347 | Jul 2020 → Dec 2024 | chronic pain syndrome, insomnia | University of California, San Diego | Completed | No outcome recorded |
| Phase 2 | NCT03679013 | Apr → Jul 2019 | — | Inova Health Care Services | Completed | No outcome recorded |
| Phase 2 | NCT03708237 | Feb → Nov 2019 | end stage renal failure, restless legs syndrome | University of Alberta | Terminated | No outcome recorded |
| Phase 2 | NCT03818919 | Jan 2019 → Dec 2020 | rotator cuff syndrome | Henry Ford Health System | Completed | No outcome recorded |
| Phase 2 | NCT03749642 | Nov 2018 → Jun 2020 | diabetic polyneuropathy | Angelini Pharma | Completed | No outcome recorded |
| Phase 2 | NCT03423264 | Jan 2018 → Nov 2022 | human papillomavirus-related squamous cell carcinoma, oropharynx cancer | University of Chicago | Withdrawn | No outcome recorded |
| Phase 2 | NCT03334721 | Oct 2017 → Jul 2019 | bipolar I disorder, bipolar II disorder, cannabis dependence | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 2 | NCT03220776 | Aug 2017 → Nov 2022 | alcohol-related disorders, bipolar disorder | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 2 | NCT03275012 | Apr 2017 → Oct 2019 | chronic pain syndrome | Pharmaceutical Research Management srl | Withdrawn | No outcome recorded |
| Phase 2 | NCT02349477 | Nov 2014 → Aug 2018 | alcohol dependence, alcohol withdrawal | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 2 | NCT02163434 | Jun 2014 → Oct 2019 | hyperemesis gravidarum | State University of New York at Buffalo | Completed | No outcome recorded |
| Phase 2 | NCT03023501 | Mar 2014 → Jan 2017 | — | King Saud University | Completed | No outcome recorded |
| Phase 2 | NCT01893632 | Jul 2013 → Apr 2016 | drug dependence | New York State Psychiatric Institute | Terminated | No outcome recorded |
| Phase 2 | NCT01744444 | Nov 2012 → Jul 2013 | pathologic nystagmus | Hospices Civils de Lyon | Completed | No outcome recorded |
| Phase 2 | NCT01675960 | Apr 2012 → Jul 2017 | chronic pain syndrome, digestive system disorder, insomnia, mood disorder +1 | Gillette Children's Specialty Healthcare | Terminated | No outcome recorded |
| Phase 2 | NCT01533753 | Feb 2012 → Jan 2014 | prostate cancer | University of Wisconsin, Madison | Terminated | No outcome recorded |
| Phase 2 | NCT00974376 | Nov 2009 → May 2016 | cannabis dependence, cognitive disorder, substance withdrawal syndrome | The Scripps Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT01014520 | May 2009 → Feb 2010 | vertebral column disorder | Tabriz University | Unknown | No outcome recorded |
| Phase 2 | NCT01005108 | Jan 2009 → Jan 2014 | — | Abramson Cancer Center at Penn Medicine | Completed | No outcome recorded |
| Phase 2 | NCT00420771 | Jan 2007 → Jan 2011 | opiate dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00395044 | Aug 2006 → Jul 2008 | cannabis dependence | The Scripps Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT00712439 | Apr → Nov 2006 | diabetic polyneuropathy | Depomed | Completed | No outcome recorded |
| Phase 2 | NCT00654953 | Jan 2006 → May 2009 | cocaine dependence, depressive disorder | University of Arkansas | Completed | No outcome recorded |
| Phase 2 | NCT00755508 | Nov 2005 → Sep 2006 | sleep disorder, initiating and maintaining sleep | Takeda | Completed | No outcome recorded |
| Phase 2 | NCT00108550 | Oct 2004 → Jul 2009 | chronic pain syndrome | US Department of Veterans Affairs | Completed | No outcome recorded |
| Phase 2 | NCT00391716 | Feb 2004 → Jul 2009 | alcohol dependence | The Scripps Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT00257270 | Aug 2003 → Jan 2005 | tinnitus | Tinnitus Research Consortium | Completed | No outcome recorded |
| Phase 2 | NCT01210079 | Sep 2002 → Mar 2008 | — | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 2 | NCT00229125 | Jul 2001 → Sep 2005 | alcohol withdrawal | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | No outcome recorded |
| Phase 2 | NCT00001482 | May 1995 → May 2001 | anxiety disorder, mood disorder, psychotic disorder | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
| Phase 2 | NCT00011297 | ? → Dec 2005 | alcohol dependence | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | No outcome recorded |
| Phase 2/311 trials | ||||||
| Phase 2/3 | NCT04939987 | Aug → Oct 2022 | — | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03825809 | Jan 2019 → Jan 2020 overdue | substance-related disorder | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 2/3 | NCT03818932 | Jan 2019 → Jan 2020 | — | Henry Ford Health System | Completed | No outcome recorded |
| Phase 2/3 | NCT03566394 | Jul 2018 → Jun 2019 | chemotherapy-induced toxicity, invasive breast carcinoma | British Columbia Cancer Agency | Unknown | No outcome recorded |
| Phase 2/3 | NCT03496389 | Jul 2018 → Jul 2019 | — | Hospital Authority, Hong Kong | Unknown | No outcome recorded |
| Phase 2/3 | NCT02355886 | Apr 2015 → Feb 2018 | urinary bladder carcinoma | University of Washington | Completed | No outcome recorded |
| Phase 2/3 | NCT02099006 | Nov 2013 → Jun 2015 | female reproductive system disorder | University of Rochester | Completed | No outcome recorded |
| Phase 2/3 | NCT01486706 | Oct 2010 → Oct 2014 | overactive bladder | Michael E. Chua | Completed | No outcome recorded |
| Phase 2/3 | NCT00262639 | Dec 2005 → Feb 2008 | alcohol dependence | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 2/3 | NCT00317850 | Apr 2004 → Feb 2006 | tinnitus | Washington University School of Medicine | Terminated | No outcome recorded |
| Phase 2/3 | NCT00057278 | Mar 2003 → Jan 2006 | fibromyalgia | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Completed | No outcome recorded |
| Phase 356 trials | ||||||
| Phase 3 | NCT02219373 | Jun 2026 → Dec 2028 expected | neuropathy, painful | Boston Children's Hospital | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07429734 | Feb → Oct 2026 expected | overactive bladder | Mansoura University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06992427 | Jun 2025 → Aug 2029 expected | head and neck squamous cell carcinoma | Alliance for Clinical Trials in Oncology | Recruiting | No outcome recorded |
| Phase 3 | NCT05921604 | Jun 2023 → Aug 2025 overdue | — | Tanta University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT05620641 | Oct 2022 → Feb 2025 | morbid obesity | Tanta University | Completed | No outcome recorded |
| Phase 3 | NCT05100160 | Sep 2021 → Jan 2023 | lung disorder | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT04429022 | Nov 2020 → May 2022 | — | State University of New York at Buffalo | Completed | No outcome recorded |
| Phase 3 | NCT04230980 | Jul 2020 → Nov 2022 | azoospermia | Weill Medical College of Cornell University | Completed | No outcome recorded |
| Phase 3 | NCT04176419 | Jan 2020 → Jun 2021 | — | Case Comprehensive Cancer Center | Terminated | No outcome recorded |
| Phase 3 | NCT03867240 | Jun 2019 → Sep 2022 | idiopathic scoliosis, neuropathy, painful | Emory University | Withdrawn | No outcome recorded |
| Phase 3 | NCT03747562 | Mar 2019 → Jul 2022 | head and neck cancer, neuropathy, painful, radiation-induced neuropathy | University Hospital, Ghent | Withdrawn | No outcome recorded |
| Phase 3 | NCT03682367 | Dec 2018 → Apr 2020 | head and neck cancer | University of California, Davis | Terminated | No outcome recorded |
| Phase 3 | NCT02722603 | Sep 2018 → May 2019 | chronic pain syndrome | Pharmaceutical Research Management srl | Terminated | No outcome recorded |
| Phase 3 | NCT02987985 | Oct 2017 → Sep 2019 | obstructive sleep apnea syndrome, respiratory underresponsiveness to hypoxia and hypercapnia | University of Saskatchewan | Completed | No outcome recorded |
| Phase 3 | NCT03330119 | Oct 2017 → Jun 2018 | pregnancy disorder, substance-related disorder | Brest, Norman A., M.D. | Terminated | No outcome recorded |
| Phase 3 | NCT03186443 | Oct 2017 | neuralgia | Second Affiliated Hospital of Guangzhou Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT03255330 | Oct 2017 → Feb 2020 | spinal cord injury | Masaryk University | Withdrawn | No outcome recorded |
| Phase 3 | NCT03269344 | Jun 2017 → Dec 2020 | oropharynx cancer | Henry Ford Health System | Completed | No outcome recorded |
| Phase 3 | NCT02999724 | Jan → Sep 2017 | pelvic organ prolapse | Mount Sinai Hospital, Canada | Unknown | No outcome recorded |
| Phase 3 | NCT02918760 | Mar → Dec 2016 | pelvis syndrome | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT03158376 | Sep 2015 → May 2019 | chronic pain syndrome | University Hospital, Lille | Completed | No outcome recorded |
| Phase 3 | NCT02480114 | Jul 2015 → Sep 2019 | head and neck cancer, mucositis, radiation-induced disorder | Vanderbilt-Ingram Cancer Center | Completed | No outcome recorded |
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 3 | NCT02384187 | Jan → May 2015 | — | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT01888497 | Jul → Dec 2013 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01776671 | Feb 2013 → Nov 2018 | — | Chicago Anesthesia Pain Specialists | Unknown | No outcome recorded |
| Phase 3 | NCT03274167 | Jan 2012 → Dec 2014 | alcohol abuse | Chulalongkorn University | Completed | No outcome recorded |
| Phase 3 | NCT01080300 | Aug 2010 → Sep 2011 | — | Depomed | Completed | No outcome recorded |
| Phase 3 | NCT01067144 | May 2010 → Jul 2016 | breast cancer, lung cancer | Stanford University | Terminated | No outcome recorded |
| Phase 3 | NCT01052896 | Mar 2010 → Mar 2011 | dyspepsia | 59th Medical Wing | Withdrawn | No outcome recorded |
| Phase 3 | NCT01632215 | Mar 2010 → Aug 2011 | carpal tunnel syndrome | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 3 | NCT00880191 | Apr 2009 → Mar 2011 | cancer of unknown primary site | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 3 | NCT01052844 | Jan 2009 → Jul 2010 | cisplatin toxicity | Faculdade de Medicina do ABC | Completed | No outcome recorded |
| Phase 3 | NCT00777023 | Oct 2008 → Jul 2009 | — | Depomed | Completed | No outcome recorded |
| Phase 3 | NCT00755417 | Sep 2008 → Aug 2009 | — | Depomed | Completed | No outcome recorded |
| Phase 3 | NCT00620555 | May 2008 → Dec 2010 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00684112 | May 2008 → Dec 2009 | scoliosis | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00636636 | Mar 2008 → Aug 2009 | postherpetic neuralgia | Depomed | Completed | No outcome recorded |
| Phase 3 | NCT00603473 | Jan 2008 → Dec 2009 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00659100 | Aug 2006 → Jan 2007 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00335933 | May 2006 → Jul 2007 | postherpetic neuralgia | Depomed | Completed | No outcome recorded |
| Phase 3 | NCT00312260 | Apr 2006 → May 2010 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00674752 | Mar → Aug 2006 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00221338 | Jan 2006 → Jan 2014 | delirium | University of California, San Francisco | Completed | No outcome recorded |
| Phase 3 | NCT00163046 | Oct 2005 → Apr 2006 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00666575 | Dec 2004 → May 2005 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00087399 | Nov 2004 → Apr 2007 | breast cancer | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 3 | NCT00666770 | Oct → Nov 2004 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00667108 | Oct 2004 → Jan 2005 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00666939 | Oct 2004 → Jan 2005 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01107574 | Apr 2004 → Dec 2009 | fibromyalgia | Good Samaritan Regional Medical Center, Oregon | Completed | No outcome recorded |
| Phase 3 | NCT00112138 | Mar 2004 → Feb 2006 | — | North Toronto Primary Care Research Network | Completed | No outcome recorded |
| Phase 3 | NCT00533455 | Mar 2004 → Aug 2007 | tremor, hereditary essential, and idiopathic normal pressure hydrocephalus | Minneapolis Veterans Affairs Medical Center | Terminated | No outcome recorded |
| Phase 3 | NCT00027963 | Feb 2002 → Nov 2007 | poisoning | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 3 | NCT00058890 | Nov 2000 → Jan 2004 | cholestasis, cirrhosis of liver | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
| Phase 3 | NCT00007670 | Jan 1998 → Mar 2003 | epilepsy | US Department of Veterans Affairs | Completed | No outcome recorded |
| Phase 473 trials | ||||||
| Phase 4 | NCT06781489 | Feb → Mar 2025 | carpal tunnel syndrome | Universidad Europea de Madrid | Completed | No outcome recorded |
| Phase 4 | NCT06254183 | Dec 2024 → May 2025 | acute kidney injury, morbid obesity | Tanta University | Completed | No outcome recorded |
| Phase 4 | NCT06379425 | Mar 2024 → Mar 2026 overdue | — | Northwell Health | Recruiting | No outcome recorded |
| Phase 4 | NCT05800847 | Apr 2023 → Apr 2024 | rotator cuff syndrome | Hughston Clinic | Unknown | No outcome recorded |
| Phase 4 | NCT05658887 | Jan 2023 → Dec 2024 | pelvic organ prolapse | Joseph Kowalski | Completed | No outcome recorded |
| Phase 4 | NCT05076110 | Apr 2022 → Oct 2025 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT05302999 | Mar 2022 → Aug 2026 overdue | spinal cord injury | MetroHealth Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT05063656 | Feb 2022 → Dec 2025 | autism spectrum disorder | David Cochran | Completed | No outcome recorded |
| Phase 4 | NCT04865042 | Feb 2022 → Dec 2024 | radiculopathy | Lille Catholic University | Completed | No outcome recorded |
| Phase 4 | NCT04860141 | Jun 2021 → Dec 2026 expected | neuropathy, painful, tooth disorder | Loma Linda University | Recruiting | No outcome recorded |
| Phase 4 | NCT03689114 | May 2021 → Jun 2024 | focal epilepsy | Mario Negri Institute for Pharmacological Research | Completed | No outcome recorded |
| Phase 4 | NCT05319756 | Apr → Dec 2021 | substance abuse | Viatris Specialty LLC | Completed | No outcome recorded |
| Phase 4 | NCT04705480 | Apr 2021 → Sep 2024 | — | CAMC Health System | Completed | No outcome recorded |
| Phase 4 | NCT05413902 | Apr 2021 → Jan 2022 | — | University of Puerto Rico | Completed | No outcome recorded |
| Phase 4 | NCT04570436 | Mar 2021 → Nov 2022 | substance abuse | Viatris Specialty LLC | Completed | No outcome recorded |
| Phase 4 | NCT04240626 | Jan 2021 → Jun 2026 overdue | morbid obesity | University of California, Davis | Active not recruiting | No outcome recorded |
| Phase 4 | NCT04522206 | Aug 2020 → Jun 2021 | vertebral column disorder | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT02927405 | Mar 2020 | — | State University of New York - Downstate Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT04246697 | Nov 2019 → Jun 2021 | head and neck cancer | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT04068506 | Sep 2019 → Jan 2020 | — | Dow University of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02957097 | Sep 2019 → Jun 2021 | cranial nerve neuropathy, neuropathy, painful | Massachusetts General Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT04256603 | Aug 2019 → Mar 2020 | neuropathy, painful, spinal cord injury | MetroHealth Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03859024 | Mar 2019 → Apr 2023 | urethral stricture | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 4 | NCT03738904 | Oct 2018 → Aug 2022 | anus disorder | Cedars-Sinai Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03472521 | Sep 2018 → Jul 2020 | chronic pain syndrome, puerperal disorder, substance-related disorder | Stanford University | Completed | No outcome recorded |
| Phase 4 | NCT03549611 | Aug 2018 → Jun 2019 | nephrolithiasis | Kevin J Flynn MD | Withdrawn | No outcome recorded |
| Phase 4 | NCT03334903 | May 2018 → Apr 2019 | chronic pain syndrome, opiate dependence, osteoarthritis, knee | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03335436 | Apr 2018 → Nov 2020 | — | Vanderbilt University Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT03151746 | Jan 2018 → Dec 2021 | urethral obstruction | Northwestern University | Terminated | No outcome recorded |
| Phase 4 | NCT03121963 | Nov 2017 → Nov 2020 | — | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
| Phase 4 | NCT02160301 | Nov 2017 → Dec 2019 | — | University of North Carolina, Chapel Hill | Withdrawn | No outcome recorded |
| Phase 4 | NCT05024825 | Aug 2017 → May 2021 | — | Albany Medical College | Terminated | No outcome recorded |
| Phase 4 | NCT03681574 | Jul 2017 → Jul 2018 | acute stress disorder, neuropathy, painful | Hospital Infantil Albert Sabin | Completed | No outcome recorded |
| Phase 4 | NCT03635905 | May 2017 → May 2019 | — | Medstar Health Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT03393702 | May 2017 → Dec 2019 | neuropathy, painful | National Institute for Tuberculosis and Lung Diseases, Poland | Completed | No outcome recorded |
| Phase 4 | NCT03012815 | Feb 2017 → Mar 2021 | alcohol withdrawal | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02958566 | Jan → Dec 2017 | colon carcinoma, constipation disorder, diverticulitis of colon, paralytic ileus +1 | University of Illinois College of Medicine at Peoria | Unknown | No outcome recorded |
| Phase 4 | NCT02944656 | Dec 2016 → Jun 2018 | — | Emory University | Completed | No outcome recorded |
| Phase 4 | NCT03241875 | Dec 2016 → Aug 2017 | gallbladder disorder, neuropathy, painful | Faculty of Medicine, Sousse | Completed | No outcome recorded |
| Phase 4 | NCT02944981 | Aug 2016 → Feb 2017 | — | Khon Kaen University | Completed | No outcome recorded |
| Phase 4 | NCT02771925 | Jun 2016 → Apr 2018 | alcohol dependence | Dayanand Medical College and Hospital | Terminated | No outcome recorded |
| Phase 4 | NCT02867176 | Jan → Jul 2016 | — | Instituto de Oftalmología Fundación Conde de Valenciana | Completed | No outcome recorded |
| Phase 4 | NCT02693821 | Dec 2015 → Jan 2016 | — | Hospital Italiano de Buenos Aires | Completed | No outcome recorded |
| Phase 4 | NCT03047278 | Nov 2015 → May 2018 | diabetic neuropathy, neuropathy, painful, type 2 diabetes mellitus | Natalia Valadares de Moraes | Completed | No outcome recorded |
| Phase 4 | NCT02599701 | Sep → Nov 2015 | — | Associação Fundo de Incentivo à Pesquisa | Terminated | No outcome recorded |
| Phase 4 | NCT02359110 | Jun 2015 → Jan 2017 | — | Milton S. Hershey Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT02466191 | Jun 2015 → Jan 2016 | pathologic nystagmus | Hospices Civils de Lyon | Completed | No outcome recorded |
| Phase 4 | NCT02595190 | Mar 2015 → Mar 2020 | pain agnosia | Southwest Hospital, China | Unknown | No outcome recorded |
| Phase 4 | NCT02330094 | Dec 2014 → Sep 2017 | acquired aneurysmal subarachnoid hemorrhage | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02127853 | Jul 2014 → Feb 2016 | — | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03005483 | Jan 2014 → Jan 2015 | musculoskeletal system disorder | Hospital Infantil Albert Sabin | Completed | No outcome recorded |
| Phase 4 | NCT01977937 | Nov 2013 → Apr 2018 | neuropathy, painful | Oregon Health and Science University | Completed | No outcome recorded |
| Phase 4 | NCT01868425 | Apr 2013 → Dec 2017 | — | University of Wisconsin, Madison | Completed | No outcome recorded |
| Phase 4 | NCT01764464 | Dec 2012 → Mar 2016 | — | University of Rochester | Completed | No outcome recorded |
| Phase 4 | NCT01364298 | Apr 2011 → Jul 2012 | diabetic polyneuropathy | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
| Phase 4 | NCT01127100 | May 2010 → Nov 2011 | neuropathy, painful, spinal stenosis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01177514 | Apr → Sep 2010 | — | Codet Vision Institute | Completed | No outcome recorded |
| Phase 4 | NCT00785772 | Mar → Apr 2010 | impaired renal function disease | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT02074267 | Mar 2009 → Jun 2011 | peripheral neuropathy | Nang Kuang Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT00584779 | Oct → Dec 2007 | — | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT00855738 | May 2007 → Jun 2009 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01022736 | May → Sep 2007 | — | Queen's University | Completed | No outcome recorded |
| Phase 4 | NCT01966172 | Mar 2007 → Aug 2009 | — | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT00209885 | Oct 2005 → ? | cholecystolithiasis | Hvidovre University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00209872 | Oct 2005 → ? | — | Hvidovre University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00236223 | Oct 2005 → Apr 2008 | — | Glostrup University Hospital, Copenhagen | Terminated | No outcome recorded |
| Phase 4 | NCT00666796 | Apr → May 2005 | insomnia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01573052 | Mar 2004 → Aug 2010 | alcohol withdrawal | VA Salt Lake City Health Care System | Completed | No outcome recorded |
| Phase 4 | NCT00153283 | Sep 2003 → Apr 2004 | asthma | Centre of Chinese Medicine, Georgia | Completed | No outcome recorded |
| Phase 4 | NCT00644748 | May 2003 → Aug 2004 | diabetic neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00189072 | Apr 2003 → ? | neuropathy, painful | UMC Utrecht | Terminated | No outcome recorded |
| Phase 4 | NCT00169013 | May 2002 → Jun 2006 | — | Danish Pain Research Center | Completed | No outcome recorded |
| Phase 4 | NCT00276081 | May 2002 → Sep 2004 | — | University of Rochester | Completed | No outcome recorded |
| Phase not applicable39 trials | ||||||
| — | NCT07169006 | Jan → Jun 2026 overdue | — | Ain Shams University | Not yet recruiting | No outcome recorded |
| — | NCT07389551 | Jul → Dec 2025 | — | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT07019103 | Mar 2025 → Oct 2026 expected | — | Haroon Muhammad Khalil | Active not recruiting | No outcome recorded |
| — | NCT07515456 | Dec 2024 → Nov 2026 expected | intracranial hypotension | Tanta University | Recruiting | No outcome recorded |
| — | NCT05997355 | Sep 2023 → Jul 2024 | — | University of Puerto Rico | Unknown | No outcome recorded |
| — | NCT06112223 | Apr → Sep 2023 | — | Tanta University | Completed | No outcome recorded |
| — | NCT07267182 | Aug 2022 → Feb 2023 | — | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT04818450 | Apr 2021 → Jun 2022 | critical illness polyneuropathy | Mahidol University | Completed | No outcome recorded |
| — | NCT06354478 | Jan 2021 → Feb 2022 | breast cancer | National Cancer Institute, Egypt | Completed | No outcome recorded |
| — | NCT04491786 | Aug 2020 → May 2021 | — | Gia Dinh People Hospital | Completed | No outcome recorded |
| — | NCT07644065 | Sep 2019 → May 2020 | anxiety, impacted teeth, multiple | Plovdiv Medical University | Completed | No outcome recorded |
| — | NCT04148846 | Sep 2019 → Sep 2020 | headache disorder | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| — | NCT03826615 | Feb 2019 → Jan 2020 | cataract | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT03859102 | Dec 2018 → Oct 2019 | aneurysm or dilatation of ascending aorta, aortic valve disorder, cardiac valvular defect, coronary artery disorder +2 | James Cook University Hospital | Unknown | No outcome recorded |
| — | NCT03351439 | Apr 2018 → Sep 2021 | chronic pain syndrome | Western University, Canada | Completed | No outcome recorded |
| — | NCT04176783 | Mar 2018 → Jul 2021 | — | OrthoCarolina Research Institute, Inc. | Completed | No outcome recorded |
| — | NCT04003350 | Dec 2017 → Nov 2018 | osteoarthritis, knee | Rothman Institute Orthopaedics | Completed | No outcome recorded |
| — | NCT02605187 | Nov 2015 → May 2017 | — | Stanford University | Completed | No outcome recorded |
| — | NCT02306278 | Dec 2014 → Dec 2015 | neoplasm of cerebral hemisphere | Capital Medical University | Completed | No outcome recorded |
| — | NCT02402543 | Jun 2014 → May 2017 | anal fistula, anogenital human papillomavirus infection, hemorrhoid | University of Vermont | Completed | No outcome recorded |
| — | NCT02202707 | May 2014 → Jun 2016 | — | Beth Israel Deaconess Medical Center | Withdrawn | No outcome recorded |
| — | NCT04345432 | Jan 2014 → Sep 2017 | postural orthostatic tachycardia syndrome | Medstar Health Research Institute | Completed | No outcome recorded |
| — | NCT02040532 | Jan 2014 → Aug 2015 | vascular disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01623271 | May 2013 → Jun 2014 | complex regional pain syndrome type 1 | Massachusetts General Hospital | Terminated | No outcome recorded |
| — | NCT02052414 | Jul 2012 → Nov 2013 | fibromyalgia | The Center for Clinical Research, Winston-Salem, NC | Completed | No outcome recorded |
| — | NCT01255878 | Mar → Sep 2010 | parasomnia, sleep bruxism type | Mashhad University of Medical Sciences | Completed | No outcome recorded |
| — | NCT01265056 | Feb 2010 → Sep 2011 | — | Lucy A Wibbenmeyer | Completed | No outcome recorded |
| — | NCT00954187 | Nov 2009 → Sep 2012 | — | Loma Linda University | Terminated | No outcome recorded |
| — | NCT00386243 | Dec 2007 → May 2012 | chronic pain syndrome | VA Office of Research and Development | Completed | No outcome recorded |
| — | NCT01307202 | Oct 2007 → Feb 2011 | — | McMaster University | Completed | No outcome recorded |
| — | NCT00889148 | Oct 2007 → Feb 2011 | — | McMaster University | Completed | No outcome recorded |
| — | NCT00588159 | Jun 2007 → Jan 2010 | — | Michelle Kinney | Completed | No outcome recorded |
| — | NCT00218374 | Oct 2006 → Jun 2007 | opiate dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| — | NCT00577967 | Oct 2005 → Mar 2006 | uremia | Hospital Authority, Hong Kong | Unknown | No outcome recorded |
| — | NCT00187707 | Sep 2005 → Jan 2007 | — | University of California, San Francisco | Completed | No outcome recorded |
| — | NCT00159588 | Jan 2004 → Nov 2006 | headache disorder | Norwegian University of Science and Technology | Completed | No outcome recorded |
| — | NCT01250561 | Feb 2002 → Oct 2007 | herpes zoster, postherpetic neuralgia | Center for Clinical Studies, Texas | Completed | No outcome recorded |
| — | NCT00022074 | Jul 2001 → Jun 2005 | anxiety disorder, breast cancer, depressive disorder | Gary Morrow | Completed | No outcome recorded |
| — | NCT00018291 | Jan 2001 → Jan 2005 | Alzheimer disease | US Department of Veterans Affairs | Completed | No outcome recorded |
Also used as a comparator or background therapy in 181 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 09 trials | ||||||
| Phase 0 | NCT04613024 Comparator | Jul → Dec 2025 | — | Stanford University | Withdrawn | No outcome recorded |
| Phase 0 | NCT07016451 Background | Apr 2024 → Sep 2025 | radiation cystitis | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 0 | NCT06212830 Comparator | Feb 2024 → Feb 2025 | — | Assaf-Harofeh Medical Center | Unknown | No outcome recorded |
| Phase 0 | NCT05659810 Comparator | Dec 2022 → Mar 2023 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 0 | NCT05609682 Comparator | Nov 2022 → May 2024 | — | University of Oklahoma | Completed | No outcome recorded |
| Phase 0 | NCT05301205 Comparator | Jun 2021 → Jun 2023 | — | Cairo University | Unknown | No outcome recorded |
| Phase 0 | NCT04622618 Comparator | Sep 2020 → Jan 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 0 | NCT03088306 Comparator | Jul 2017 → May 2018 | lumbar disk degenerative disorder, lumbar spinal stenosis | Johns Hopkins University | Completed | No outcome recorded |
| Phase 0 | NCT04292171 Comparator | May 2017 → Mar 2018 | — | University of Nevada, Las Vegas | Completed | No outcome recorded |
| Phase 17 trials | ||||||
| Phase 1 | NCT06752486 Comparator | Dec 2024 → May 2025 overdue | — | Research Institute of Ophthalmology, Egypt | Recruiting | No outcome recorded |
| Phase 1 | NCT06776445 Comparator | Jan 2024 → Jul 2025 | rosacea | First Affiliated Hospital of Chongqing Medical University | Completed | No outcome recorded |
| Phase 1 | NCT05104424 Comparator | Dec 2021 → Aug 2022 | olfactory nerve disorder, oral sensibility, disturbance of | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 1 | NCT04802967 Comparator | Feb 2021 → Mar 2022 | — | Dompé Farmaceutici S.p.A | Completed | No outcome recorded |
| Phase 1 | NCT03498261 Comparator | Jan 2018 → Dec 2025 overdue | neuropathy, painful, substance-related disorder | Ohio State University | Active not recruiting | No outcome recorded |
| Phase 1 | NCT02490345 Comparator | Oct 2015 → Jun 2017 | substance abuse | Indiana University | Completed | No outcome recorded |
| Phase 1 | NCT01119222 Comparator | Jul → Oct 2008 | — | Pfizer | Completed | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT04434430 Comparator | Nov 2019 → Feb 2020 | — | Indonesia University | Completed | No outcome recorded |
| Phase 1/2 | NCT03750773 Comparator | Jul 2019 → Mar 2020 | — | Indiana University | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT01200641 Comparator | Sep → Dec 2010 | anxiety | Qazvin University Of Medical Sciences | Completed | No outcome recorded |
| Phase 220 trials | ||||||
| Phase 2 | NCT05443555 Comparator | Nov 2023 → Oct 2026 expected | HIV infectious disease, alcohol abuse | Boston Medical Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06091553 Comparator | Oct 2023 → Sep 2024 | peripheral neuropathy | Beni-Suef University | Unknown | No outcome recorded |
| Phase 2 | NCT05494437 Comparator | Oct 2022 → Aug 2023 | substance withdrawal syndrome | PleoPharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT04052139 Comparator | Jan → Nov 2021 | HIV infectious disease, alcohol-related disorders, chronic pain syndrome | Boston Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT03574792 Background | May 2018 → Apr 2021 | head and neck squamous cell carcinoma | Roswell Park Cancer Institute | Completed | No outcome recorded |
| Phase 2 | NCT03205423 Comparator | Aug 2017 → Jun 2021 | alcohol dependence, opiate dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT03084536 Comparator | Jun 2017 → Feb 2021 | female breast carcinoma | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT02725710 Comparator | Aug 2016 → Jun 2018 | pregnancy disorder with abortive outcome | Duke University | Completed | No outcome recorded |
| Phase 2 | NCT02252926 Background | Sep 2014 → Dec 2015 | mucositis | Hvidovre University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01954927 Comparator | Oct 2013 → Jan 2018 | sickle cell disease | St. Jude Children's Research Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01588314 Comparator | Apr 2012 → Jun 2014 | Fabry disease, neuropathy, painful | University of Minnesota | Withdrawn | No outcome recorded |
| Phase 2 | NCT01506453 Comparator | Jan 2012 → Jan 2018 | acute lymphoblastic leukemia, neuropathy, painful, peripheral neuropathy | St. Jude Children's Research Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01262092 Comparator | Oct 2010 → Dec 2011 | opiate dependence, substance withdrawal syndrome | University of Arkansas | Completed | No outcome recorded |
| Phase 2 | NCT00967707 Comparator | Aug 2009 → Apr 2011 | traumatic neuropathy | Uppsala University | Completed | No outcome recorded |
| Phase 2 | NCT00578552 Comparator | Oct 2007 → Feb 2009 | nicotine dependence | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT00475904 Comparator | Jul 2007 → Jun 2008 | postherpetic neuralgia | EpiCept Corporation | Completed | No outcome recorded |
| Phase 2 | NCT00511953 Comparator | Jun → Dec 2007 | — | Depomed | Completed | No outcome recorded |
| Phase 2 | NCT00555776 Comparator | Jan 2007 → Apr 2008 | tinnitus | Islamic Azad University of Mashhad | Unknown | No outcome recorded |
| Phase 2 | NCT00414466 Comparator | Dec 2006 → Dec 2009 | chronic pain syndrome | MedtronicNeuro | Terminated | No outcome recorded |
| Phase 2 | NCT00250744 Comparator | Dec 2004 → Sep 2007 | cancer | New Mexico Cancer Research Alliance | Completed | No outcome recorded |
| Phase 2/313 trials | ||||||
| Phase 2/3 | NCT07047040 Comparator | Aug 2025 → Oct 2027 expected | neuropathy, painful, osteoarthritis, knee | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT07625410 Comparator | May 2023 → May 2024 | — | Rehman Medical Institute - RMI | Completed | No outcome recorded |
| Phase 2/3 | NCT04724252 Comparator | Aug 2021 → Dec 2026 expected | neuropathy, painful | University of California, Davis | Recruiting | No outcome recorded |
| Phase 2/3 | NCT04562610 Comparator | Nov 2020 → Oct 2024 | vertebral column disorder | University of California, Davis | Completed | No outcome recorded |
| Phase 2/3 | NCT04689971 Background | Nov 2020 → Nov 2021 | neuropathy, painful | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04689984 Background | Nov 2020 → Nov 2021 | diabetic polyneuropathy | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04689958 Background | Nov 2020 → Nov 2021 | diabetic polyneuropathy | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03172234 Comparator | Jun 2017 → May 2018 | — | Ghada Mohammed AboelFadl | Completed | No outcome recorded |
| Phase 2/3 | NCT02543944 Comparator | Feb 2016 → May 2021 | drug dependence | University of Arkansas | Completed | No outcome recorded |
| Phase 2/3 | NCT02525848 Comparator | Aug 2015 → Mar 2016 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT01141049 Comparator | Aug 2010 → Dec 2012 | alcohol dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2/3 | NCT00735124 Comparator | Nov 2008 → Sep 2009 | — | University of Oklahoma | Terminated | No outcome recorded |
| Phase 2/3 | NCT00260481 Comparator | Jan 2006 → Jun 2008 | drug dependence, substance abuse | University of California, Los Angeles | Completed | No outcome recorded |
| Phase 322 trials | ||||||
| Phase 3 | NCT07296770 Background | Oct 2026 → Dec 2027 expected | chronic pain syndrome | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06887998 Comparator | Mar 2025 → Feb 2026 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06561035 Background | Sep 2024 → Aug 2025 overdue | — | Campbell Clinic | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT05827159 Background | Aug 2024 → Dec 2027 expected | alcohol-related disorders | Yale University | Recruiting | No outcome recorded |
| Phase 3 | NCT05965492 Background | Jun 2024 → Jun 2025 | spinal cord disorder | University of Miami | Withdrawn | No outcome recorded |
| Phase 3 | NCT07349680 Background | Mar 2023 → Sep 2025 | postherpetic neuralgia | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT05658874 Background | Dec 2022 → Dec 2024 | interstitial cystitis, levator syndrome | Jocelyn Fitzgerald | Terminated | No outcome recorded |
| Phase 3 | NCT05427474 Comparator | Dec 2022 → Sep 2023 | traumatic brain injury | Zagazig University | Unknown | No outcome recorded |
| Phase 3 | NCT05539924 Comparator | Sep → Nov 2022 | substance-related disorder | Research Institute of Ophthalmology, Egypt | Unknown | No outcome recorded |
| Phase 3 | NCT04144933 Comparator | May 2021 → Jul 2024 | paralytic ileus | University of Saskatchewan | Unknown | No outcome recorded |
| Phase 3 | NCT05172570 Comparator | Apr 2021 → Feb 2022 | — | Indiana University | Terminated | No outcome recorded |
| Phase 3 | NCT03806530 Comparator | May 2019 → Dec 2021 | end stage renal failure, restless legs syndrome | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT02642484 Comparator | Dec 2018 → Dec 2022 | cirrhosis of liver | Tanta University | Unknown | No outcome recorded |
| Phase 3 | NCT01116583 Comparator | May 2011 → Nov 2013 | neuropathy, painful | University of Aarhus | Completed | No outcome recorded |
| Phase 3 | NCT02120703 Comparator | Feb → Oct 2011 | lumbar disk disease | Aga Khan University | Completed | No outcome recorded |
| Phase 3 | NCT00934193 Comparator | Jul 2009 → Jun 2011 | — | University of Kansas Medical Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT00711529 Comparator | Jul 2008 → Jun 2011 | breast cancer | Women and Infants Hospital of Rhode Island | Completed | No outcome recorded |
| Phase 3 | NCT01263132 Comparator | Feb 2008 → Feb 2010 | diabetic polyneuropathy, polyneuropathy | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
| Phase 3 | NCT00624455 Comparator | Jul 2007 → Dec 2008 | — | University of British Columbia | Completed | No outcome recorded |
| Phase 3 | NCT00137735 Comparator | Oct 2003 → Dec 2006 | carpal tunnel syndrome | Chinese University of Hong Kong | Completed | No outcome recorded |
| Phase 3 | NCT00183196 Comparator | Jan 2003 → Dec 2008 | alcohol dependence | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 3 | NCT00028574 Comparator | Dec 2001 → Dec 2006 | prostate cancer | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 457 trials | ||||||
| Phase 4 | NCT07158476 Comparator | Oct 2025 → Sep 2030 expected | — | St. Louis University | Recruiting | No outcome recorded |
| Phase 4 | NCT06935331 Background | Oct 2025 → Dec 2026 expected | adolescent idiopathic scoliosis | OrthoCarolina Research Institute, Inc. | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT06997016 Background | May 2025 → Jun 2026 overdue | — | Baylor Research Institute | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT06778798 Comparator | Feb → Mar 2025 | carpal tunnel syndrome | Universidad Europea de Madrid | Completed | No outcome recorded |
| Phase 4 | NCT06466421 Comparator | Jul → Oct 2024 | end stage renal failure | Tanta University | Completed | No outcome recorded |
| Phase 4 | NCT06346522 Comparator | Apr → Sep 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT05820685 Background | Jul 2023 → Apr 2024 | nervous system injury | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded |
| Phase 4 | NCT05875610 Comparator | May → Oct 2023 | chemotherapy-induced neuropathy | Mit Ghamr Oncology Center | Unknown | No outcome recorded |
| Phase 4 | NCT05626998 Comparator | Nov 2022 → Apr 2023 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT05750875 Comparator | May → Oct 2022 | chronic kidney disease, uremia | King Edward Medical University | Completed | No outcome recorded |
| Phase 4 | NCT05324761 Comparator | Apr → Jun 2022 | — | Al-Kindy College of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT05231460 Comparator | Feb 2022 → Jun 2026 overdue | neuropathy, painful | University of Arizona | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT04990804 Background | Aug 2021 → Feb 2022 | spinal cord disorder, substance-related disorder | Vanderbilt University Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT05494385 Comparator | Jul 2021 → Jun 2023 | — | Indiana University | Completed | No outcome recorded |
| Phase 4 | NCT05690282 Comparator | May 2021 → Dec 2024 overdue | — | University of California, San Diego | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05296759 Comparator | Feb → Nov 2021 | diabetic neuropathy | Alexandria University | Completed | No outcome recorded |
| Phase 4 | NCT04129086 Comparator | Jul 2020 → Mar 2022 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT04285281 Comparator | Apr → Aug 2020 | carpal tunnel syndrome | Universidad Europea de Madrid | Completed | No outcome recorded |
| Phase 4 | NCT04025203 Comparator | Aug → Nov 2019 | carpal tunnel syndrome | Francisco Unda Solano | Completed | No outcome recorded |
| Phase 4 | NCT04653415 Comparator | Jun 2019 → Jan 2020 | osteoarthritis, knee | Jagiellonian University | Completed | No outcome recorded |
| Phase 4 | NCT03619785 Comparator | Nov 2018 → Aug 2019 | myopathy, congenital, with respiratory insufficiency and bone fractures | Andrew A Herring | Unknown | No outcome recorded |
| Phase 4 | NCT03625011 Comparator | Jul 2018 → Dec 2019 overdue | tonsillitis | Children's Healthcare of Atlanta | Recruiting | No outcome recorded |
| Phase 4 | NCT03758079 Comparator | Jun → Oct 2018 | — | University of Balamand | Completed | No outcome recorded |
| Phase 4 | NCT03472469 Comparator | Apr 2018 → Jul 2019 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03123861 Comparator | Jun 2017 → Jul 2020 | pelvic organ prolapse | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 4 | NCT03080493 Comparator | Mar 2017 → Nov 2018 | — | University of California, Davis | Completed | No outcome recorded |
| Phase 4 | NCT02987920 Background | Jan 2017 → Jan 2018 | — | University of Southern California | Terminated | No outcome recorded |
| Phase 4 | NCT02977208 Comparator | Sep 2016 → Feb 2018 | chronic pain syndrome, epilepsy | São Paulo State University | Completed | No outcome recorded |
| Phase 4 | NCT03540030 Comparator | Sep 2016 → Mar 2019 | avascular necrosis, osteoarthritis, rotator cuff syndrome, substance-related disorder | OrthoCarolina Research Institute, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT02926573 Comparator | Jun 2016 → Jun 2017 | head and neck cancer | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02685735 Comparator | Jun 2016 → Feb 2022 | — | Wake Forest University Health Sciences | Terminated | No outcome recorded |
| Phase 4 | NCT02703259 Comparator | Jun 2016 → Jul 2017 | — | Christiana Care Health Services | Completed | No outcome recorded |
| Phase 4 | NCT03179345 Comparator | Sep → Nov 2015 | — | Depomed | Completed | No outcome recorded |
| Phase 4 | NCT03850093 Comparator | Aug 2015 → Oct 2016 | hypertensive disorder | Zagazig University | Completed | No outcome recorded |
| Phase 4 | NCT01112878 Comparator | Jun 2015 | — | Cedars-Sinai Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT02339662 Comparator | Feb 2015 → Jan 2016 | myofascial pain syndrome | Doron Aframian | Unknown | No outcome recorded |
| Phase 4 | NCT02351934 Background | Feb 2015 → Apr 2016 | large intestine disorder | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02155257 Comparator | Jul 2014 → Oct 2017 | osteoarthritis | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02117076 Comparator | Apr 2014 → Jun 2016 | restless legs syndrome | Theresa Zesiewicz, MD | Terminated | No outcome recorded |
| Phase 4 | NCT02076893 Comparator | Mar 2014 → Feb 2017 | — | Children's Hospitals and Clinics of Minnesota | Terminated | No outcome recorded |
| Phase 4 | NCT02110719 Comparator | Mar 2014 → Jul 2015 | constipation disorder | Hartford Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01680549 Comparator | Sep 2012 → Feb 2016 | — | Texas Tech University Health Sciences Center | Completed | No outcome recorded |
| Phase 4 | NCT01678911 Comparator | Aug 2012 → Mar 2014 | interstitial cystitis, irritable bowel syndrome, pelvis syndrome, prostatitis +1 | Shirley Ryan AbilityLab | Terminated | No outcome recorded |
| Phase 4 | NCT01546857 Comparator | Mar 2012 → Jan 2016 | — | Rutgers, The State University of New Jersey | Terminated | No outcome recorded |
| Phase 4 | NCT01507363 Comparator | Jan 2012 → Nov 2013 | — | Hvidovre University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02419443 Comparator | Aug 2011 → Sep 2015 | peripheral nerve lesion | United States Naval Medical Center, San Diego | Unknown | No outcome recorded |
| Phase 4 | NCT00885586 Comparator | Nov 2008 → Aug 2017 | herpes zoster, postherpetic neuralgia | Dominik Irnich | Completed | No outcome recorded |
| Phase 4 | NCT00537940 Comparator | Feb 2008 → Jul 2013 | complex partial epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00619983 Comparator | Feb 2008 → May 2013 | chronic pain syndrome, diabetic neuropathy | Wake Forest University | Terminated | No outcome recorded |
| Phase 4 | NCT00552526 Comparator | Nov 2007 → Jan 2011 | epilepsy | Oslo University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00800527 Comparator | Nov 2007 → Jun 2008 | — | Usak State Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00982800 Comparator | Jun 2007 → Jan 2010 | prostate cancer | Sunnybrook Health Sciences Centre | Completed | No outcome recorded |
| Phase 4 | NCT00634543 Comparator | Dec 2006 → Oct 2008 | diabetic neuropathy | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 4 | NCT00385671 Background | Sep 2006 → Aug 2009 | diabetic polyneuropathy | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 4 | NCT00799149 Comparator | Jun 2006 → May 2007 | — | Meir Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT04523935 Comparator | Dec 2005 → Aug 2020 | cerebral palsy | Sathbhavana Brain Clinic | Completed | No outcome recorded |
| Phase 4 | NCT00904202 Comparator | Jan → Jun 2003 | carpal tunnel syndrome, complex regional pain syndrome, diabetic neuropathy, infectious neuropathy +2 | Endo USA Inc., a Keenova Therapeutics Company | Completed | No outcome recorded |
| Phase not applicable50 trials | ||||||
| — | NCT07000201 Comparator | Sep → Dec 2025 overdue | anxiety | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT07131527 Comparator | Jul 2025 → Jan 2026 | cholecystitis | Sohag University | Completed | No outcome recorded |
| — | NCT06893172 Comparator | Apr → Aug 2025 overdue | postherpetic neuralgia | University of Medicine and Pharmacy at Ho Chi Minh City | Not yet recruiting | No outcome recorded |
| — | NCT06570577 Background | Feb 2025 → Mar 2027 expected | neuropathy, painful | Stony Brook University | Recruiting | No outcome recorded |
| — | NCT06798662 Background | Feb → Jun 2025 overdue | herpes zoster | Xiaguang Duan | Not yet recruiting | No outcome recorded |
| — | NCT06301061 Comparator | Apr 2024 → Oct 2025 | chronic pain syndrome, neuropathy, painful, radiculopathy | Federico II University | Unknown | No outcome recorded |
| — | NCT07593313 Background | Jan 2024 → Aug 2026 overdue | — | Nanchong Central Hospital | Recruiting | No outcome recorded |
| — | NCT06237595 Comparator | Sep 2023 → Oct 2024 | fibromyalgia | Kasr El Aini Hospital | Unknown | No outcome recorded |
| — | NCT05690737 Comparator | Sep 2023 → Dec 2025 overdue | migraine disorder | The Hong Kong Polytechnic University | Recruiting | No outcome recorded |
| — | NCT07348952 Background | Sep 2023 → Jan 2025 | pudendal neuralgia | Cairo University | Completed | No outcome recorded |
| — | NCT06190132 Comparator | Apr → Jul 2023 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT05699876 Comparator | Jan → Nov 2023 | anxiety | All India Institute of Medical Sciences | Unknown | No outcome recorded |
| — | NCT05436314 Background | Jul 2022 → Aug 2023 | fibromyalgia | Kutahya Health Sciences University | Completed | No outcome recorded |
| — | NCT07297888 Comparator | Jul 2022 → Jan 2024 | — | Shri Guru Ram Rai Institute of Medical and Health Sciences | Completed | No outcome recorded |
| — | NCT05392361 Comparator | Jun 2022 → Mar 2023 | lumbar spinal stenosis | Yonsei University | Completed | No outcome recorded |
| — | NCT05384210 Comparator | Jun 2022 → Oct 2023 | fibromyalgia | Mansoura University | Unknown | No outcome recorded |
| — | NCT05474040 Comparator | Dec 2021 → Dec 2022 | — | Zagazig University | Completed | No outcome recorded |
| — | NCT04976374 Comparator | May → Nov 2021 | — | National Cancer Institute, Egypt | Unknown | No outcome recorded |
| — | NCT04010266 Background | Mar 2021 → Aug 2022 | arthropathy, substance-related disorder | AppliedVR Inc. | Completed | No outcome recorded |
| — | NCT03636958 Background | Feb 2021 → Jul 2025 | epilepsy | Assistance Publique Hopitaux De Marseille | Withdrawn | No outcome recorded |
| — | NCT04594226 Background | Nov 2020 → Dec 2021 | postherpetic neuralgia | The Third Affiliated hospital of Zhejiang Chinese Medical University | Completed | No outcome recorded |
| — | NCT03521167 Comparator | May 2018 → May 2019 | cardiac valvular defect | Shanghai Zhongshan Hospital | Unknown | No outcome recorded |
| — | NCT03120962 Background | May 2017 → May 2020 | herpes zoster, postherpetic neuralgia | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
| — | NCT03202459 Comparator | Mar → Sep 2017 | — | Faculdade de Ciências Médicas da Santa Casa de São Paulo | Unknown | No outcome recorded |
| — | NCT03149432 Background | Feb 2017 → Aug 2019 | — | Centre d'Investigation Clinique et Technologique 805 | Completed | No outcome recorded |
| — | NCT03347916 Comparator | Jan → Nov 2017 | — | Kuwait Specialized Eye Center | Unknown | No outcome recorded |
| — | NCT02737826 Comparator | May 2016 → Dec 2019 | chronic pain syndrome | Medical University of South Carolina | Completed | No outcome recorded |
| — | NCT02617121 Comparator | Nov 2015 → Aug 2016 | — | Hallym University Medical Center | Unknown | No outcome recorded |
| — | NCT01943435 Comparator | Nov 2013 → Jun 2016 | lumbar spinal stenosis | Michael Schneider, DC, PhD | Completed | No outcome recorded |
| — | NCT01848119 Comparator | May → Dec 2013 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT01489631 Comparator | Mar 2013 → Apr 2014 | — | St. Antonius Hospital | Completed | No outcome recorded |
| — | NCT01678586 Comparator | Dec 2012 → Dec 2021 | — | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01707420 Comparator | Aug 2012 → Dec 2015 | — | University of Colorado, Denver | Completed | No outcome recorded |
| — | NCT01301001 Comparator | Aug 2012 → Jan 2016 | vulvodynia | University of Tennessee | Completed | No outcome recorded |
| — | NCT01495923 Comparator | Dec 2011 → Jun 2014 | radiculopathy, sciatica | Johns Hopkins University | Completed | No outcome recorded |
| — | NCT01094925 Comparator | Apr → Dec 2010 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | No outcome recorded |
| — | NCT01143766 Comparator | Apr 2010 → Dec 2011 | — | Indiana University | Completed | No outcome recorded |
| — | NCT01236859 Comparator | Sep 2009 → Aug 2010 | — | Prince of Songkla University | Completed | No outcome recorded |
| — | NCT00793910 Comparator | Jul 2008 → Jul 2009 | — | Walter Reed Army Medical Center | Completed | No outcome recorded |
| — | NCT00886236 Comparator | Feb 2008 → Jan 2011 | morbid obesity | Medical University of South Carolina | Completed | No outcome recorded |
| — | NCT00572208 Comparator | Jan 2008 → Feb 2009 | — | Aarhus University Hospital | Unknown | No outcome recorded |
| — | NCT00573664 Comparator | Nov 2007 → Nov 2008 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Terminated | No outcome recorded |
| — | NCT01014533 Comparator | May 2007 → Sep 2011 | alcohol dependence, insomnia | Dr. Kirk Brower | Completed | No outcome recorded |
| — | NCT00570388 Comparator | Mar 2007 → Sep 2008 | alcohol dependence | Institute of Addiction Medicine | Unknown | No outcome recorded |
| — | NCT00390013 Comparator | Jan 2007 → Mar 2008 | vulvar disease, vulvodynia | Colleen Stockdale | Terminated | No outcome recorded |
| — | NCT00726999 Comparator | Jun 2006 → Jul 2008 | — | Medical College of Wisconsin | Completed | No outcome recorded |
| — | NCT00928954 Comparator | Feb 2005 → May 2009 | pathologic nystagmus | Case Western Reserve University | Completed | No outcome recorded |
| — | NCT00674687 Comparator | Jul 2004 → Jun 2006 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| — | NCT01020162 Comparator | Sep 1995 → Dec 2006 | chronic pain syndrome | Göteborg University | Completed | No outcome recorded |
| — | NCT00279487 Comparator | ? → Aug 2007 | — | Texas Health Resources | Completed | No outcome recorded |
Press releases naming this drug 9 releases
| Date | Issuer | Release |
|---|---|---|
| 2011-05-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva and Pfizer Settle Generic Neurontin® Litigation tevapharm.com ↗ |
| 2007-09-21 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Provides Update On Generic Neurontin® Litigation tevapharm.com ↗ |
| 2005-08-23 | Teva Branded Pharmaceutical Products R&D, Inc. | Court Grants Teva Summary Judgment of Non-Infringement on Gabapentin tevapharm.com ↗ |
| 2004-12-15 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approval And Launch Of Gabapentin Tablets tevapharm.com ↗ |
| 2004-10-08 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Final Approval And Launch Of Gabapentin Capsules tevapharm.com ↗ |
| 2004-04-28 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva And Alpharma Enter Into Agreement Relating To Gabapentin tevapharm.com ↗ |
| 2003-10-17 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Tentative Approval for Gabapentin Tablets, 600 Mg and 800 Mg tevapharm.com ↗ |
| 2003-08-07 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Tentative Approval for Gabapentin Capsules tevapharm.com ↗ |
| 2002-07-22 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approvable Status of Gabapentin Capsules tevapharm.com ↗ |
Evidence & citations 26 cited values
Every value below carries the sentence it was read from. 430 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gabapentin | “Drugs from ACT groups N03A, N05BA, N05CD, H02A or S01EC will be used including prednisolon,levetiracetam, valproate, carbamazepine, oxcarbazepine, topiramate, felbamate,...” NCT00552526 ↗415“Antiepileptic drugs allowed are therefore: lamotrigine, levetiracetam, lacosamide, sodium valproate, carbamazepine, oxcarbabazepine, slicarbazepine, pregabalin, gabapentin,...” NCT03636958 ↗ “Subjects in the oral administration group will receive the following pre-emptive analgesic drugs, acetaminophen 1,000mg, Celecoxib 200mg and gabapentin 600mg via the oral route...” NCT04562610 ↗ “Several preventive drugs based on each individual regarding type of original headache type (i.e angiotensin II blockers, betablockers, valproate, tricyclic antidepressants or...” NCT00159588 ↗ “The patients in control group continued taking their regular gabapentin and pregabalin-derivative drug therapy at the same dosage and duration specified by their physicians.” NCT05436314 ↗ “The first group will be given gabapentin orally in a dose of 300mg Tid for 72 hours and the second group will be given oral diclofenac potassium 50mg Tid for 72 hours.” NCT06752486 ↗ “Gabapentin started on day 3 of week 1, increased up to a maximum dose of 800 mg BID by day 3 of week 2 and maintained for 2 weeks followed by 5-day taper.” NCT02543944 ↗ “The second line drug such as amitriptyline and the third line drug such as gabapentin will be adopted according to doctor's judgement if necessary.” NCT05690737 ↗ “combination of medications may be used such as a local anesthesia, ibuprofen, acetaminophen, gabapentin, ketamine, lidocaine, and opioids” NCT04010266 ↗ “Buprenorphine will be given along with 2 capsules of gabapentin in the morning and 2 take-home capsules of gabapentin for night.” NCT01262092 ↗ “Gabapentin syrup at 15 mg/kg and at 30 mg/kg was administered to reduce the agitation before and after oncologic procedures” NCT03681574 ↗ “Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain” NCT02074267 ↗ “combination of Gabapentin Orally (600 mg) the night before surgery and 2 hours before anesthesia induction” NCT05474040 ↗ “Efficacy of Once Daily Gastroretentive Gabapentin (Gralise) in the Treatment of Post Amputation Pain” NCT01776671 ↗ “Will receive a single dose of gabapentin 300 mg preoperatively before standard general anesthesia” NCT07169006 ↗ “group II patients will receive two capsules of gabapentin (Conventin) 300 mg (total = 600 mg),” NCT07000201 ↗ “Gabapentin and oxycodone are commonly used in combination for the treatment of chronic pain.” NCT04315181 ↗ “4. Gabapentin 100 mg three times per day from postoperative day 1 to postoperative day 14.” NCT06561035 ↗ “Gabapentin 300 mg capsule once at night, and Duloxetine 30 mg cap once daily for 30 days.” NCT06237595 ↗ “Gabapentin has already been shown to lessen postoperative pain when given before surgery.” NCT01546857 ↗ “Acetaminophen 975 mg Celecoxib 200 mg Gabapentin 300 mg Oxycodone 10 mg Extended Release” NCT04522206 ↗ “standard treatment (pregabalin, gabapentin, or amitriptyline) over eight weeks.” PMID 34984028 ↗ Dec 2021 “medications such as Gabapentin, Tylenol, Meloxicam, Bupivacaine, or Ketorolac.” NCT04176783 ↗ “Gabapentin: 100, 200, 400 mg oral capsule may possibly be given” NCT00733239 ↗ “Adjunctive analgesics: acetaminophen, tramadol, or gabapentin” NCT01943435 ↗ “Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily” NCT04990804 ↗ “oral gabapentin 600mg and oral acetaminophen 1,000mg” NCT03738904 ↗ “gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1” NCT03330119 ↗ “The dosage of gabapentin starts from 100mg Tid.” NCT04594226 ↗ “Days 4 through 28•Gabapentin 1200 mg po 9 PM” NCT00570388 ↗ “Gabapentin 300 mg once daily for 1 month” NCT05104424 ↗ “Gabapentin, pregabalin, or amitriptyline” NCT04689984 ↗ “Gabapentin, pregabalin, or amitriptyline” NCT04689971 ↗ “Gabapentin, titrate up to 900-1200 tid” NCT00386243 ↗ “* Gabapentin 100mg three times a day” NCT05231460 ↗ “Gabapentin PO 300 mg TID x 30 days” NCT06935331 ↗ “gabapentin (1200 mg to day 40)” PMID 22082089 ↗ Nov 2011 “Gabapentin 300 mg po q8 hours” NCT04129086 ↗ “* Gabapentin / Pregabalin” NCT07016451 ↗ “Gabapentin 800mg” NCT03549611 ↗ “and Gabapentin” NCT06570577 ↗ “Gabapentin” NCT06190132 ↗ “Gabapentin” NCT07296770 ↗ “Gabapentin” NCT07296770 ↗ |
| Known as | 1-\[aminomethyl\]-cyclohexaneacetic acid | “Gabapentin (1-\[aminomethyl\]-cyclohexaneacetic acid; Neurontin, Pfizer) is an effective drug for treatment of neuropathic pain” NCT00137735 ↗ |
| Known as | Carbatin | “Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain” NCT02074267 ↗ |
| Known as | CI-945 | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Known as | Conventin | “Group G: gabapentin group in which Patients were premedicated with oral gabapentin 1200 mg (Conventin 400mg; Evapharm) with sips of water, 2 hours before induction of anesthesia.” NCT03850093 ↗1“group II patients will receive two capsules of gabapentin (Conventin) 300 mg (total = 600 mg),” NCT07000201 ↗ |
| Known as | DM-1796 | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Known as | G-ER | “A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients...” NCT00335933 ↗2“Gabapentin Extended Release (G-ER) Tablets” NCT00636636 ↗ “Gabapentin Extended-Release (G-ER) 1200 mg” NCT00777023 ↗ |
| Known as | G-GR | “To address this notion, we characterized relationships among changes in pain intensity, sleep interference, and overall impression of improvement in PHN patients treated with...” PMID 27037091 ↗ Apr 20161“gastroretentive gabapentin (G-GR)” PMID 24149930 ↗ Jun 2014 |
| Known as | Gabapentin - Neurontin | “Gabapentin - Neurontin” NCT01020162 ↗ |
| Known as | gabapentin ER | “This study aimed to determine the efficacy and safety of gabapentin extended-release (gabapentin ER) tablets for the treatment of patients with PHN and to determine whether...” PMID 20818838 ↗ 2010 |
| Known as | Gabapentin Extended Release | “Depomed's Gabapentin Extended Release is an investigational, extended release formulation of Gabapentin that is being studied for the treatment of Hot Flashes/Hot Flushes in...” NCT01080300 ↗ |
| Known as | Gabapentina | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Known as | Gabapentine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01632215 ↗ |
| Known as | gaptin | “Patients in Group B (25 participants) received gabapentin (one capsule of gaptin 100mg thrice weekly post HD session)” NCT06190132 ↗ |
| Known as | gastroretentive gabapentin | “To address this notion, we characterized relationships among changes in pain intensity, sleep interference, and overall impression of improvement in PHN patients treated with...” PMID 27037091 ↗ Apr 2016 |
| Known as | GBP | “The present study examined the impact of the N-type calcium channel blocker gabapentin (GBP) and the partial glycine agonist D-cycloserine (CYC) to attenuate the behavioral...” PMID 40272204 ↗ Apr 20252“gabapentin (GBP) plus complex B vitamins: thiamine (B1) and cyanocobalamine (B12) compared to pregabalin in patients with moderate to severe intensity PDN.” PMID 26885528 ↗ Jan 2016 “evaluated a medication combination of intravenous flumazenil (FMZ) and oral gabapentin (GBP) in alcoholics” PMID 19593171 ↗ Aug 2009 |
| Known as | GOE 3450 | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Known as | Gralise | “taking Gralise pills (gastic-retentive gabapentin) for 8 weeks.” NCT01623271 ↗ |
| Known as | Gralise: Gabapentin ER | “Gralise: Gabapentin ER” NCT01764464 ↗ |
| Known as | Neurontin | “The purpose of this study is to compare the relative bioavailability of 800 mg Gabapentin Tablets by Purepac Pharmaceutical Co. with that of 400 mg (2 x 400 mg) NEURONTIN® by...” NCT00865631 ↗17“The gabapentin (Neurontin, Pfizer, Mexico) group was instructed to take one 300-mg capsule the night before surgery and 1 capsule every 8 hours on the day of surgery and for...” NCT02867176 ↗ “Baclofen(Liofen®),Diazepam,(Valium®),Clonazepam,(Klonopin®),Trihexyphenidyl(Artane®),Tetrabenazine(Xenazine®),Gabapentin(Neurontin®),Topiramate(Topamax®),Lamotrigine(Lamictal®),...” NCT04523935 ↗ “Patients will receive 0.3 ml/kg (16 mg/kg) oral gabapentin solution (Neurontin 50 mg/ml, Pfizer Pharmaceutical) as premedication two hours before the induction of anesthesia” NCT02384187 ↗ “Gabapentin (Neurontin) will be compared to a standard benzodiazepine, lorazepam (Ativan), for its effectiveness in treating alcohol withdrawal.” NCT00011297 ↗ “Preliminary studies using the antiseizure medication, gabapentin (Neurontin), has demonstrated a substantial reduction in hot flashes.” NCT00112138 ↗ “Gabapentin group (n=15): patients in this group will receive 600mg Gabapentin (2 capsules of Neurontin 300 mg manufactured by Pfizer).” NCT04658732 ↗ “Gabapentin (1-\[aminomethyl\]-cyclohexaneacetic acid; Neurontin, Pfizer) is an effective drug for treatment of neuropathic pain” NCT00137735 ↗ “Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain” NCT02074267 ↗ “Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users” NCT05319756 ↗ “Taking gabapentin (neurontin® capsule 300mg, Pfizer) medication at night as a conservative treatment” NCT05392361 ↗ “evaluate the drug gabapentin (Neurontin®) for its ability to reduce postoperative pain” NCT00886236 ↗ “Gabapentin (Neurontin; Parke-Davis; 1200 mg/day) will be administered twice daily.” NCT00654953 ↗ “gabapentin (Neurontin; Pfizer, Cairo, Egypt)” NCT06354478 ↗ “Neurontin is the brand name for Gabapentin.” NCT01014533 ↗ “Gabapentin (Neurontin)” NCT00317850 ↗ |
| Known as | Neurontin (Registered Trademark) | “Gabapentin (Neurontin® (Registered Trademark))” NCT00001482 ↗1“Gabapentin (Neurontin® (Registered Trademark))” NCT07019103 ↗ |
| Known as | NSC-742194 | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Known as | NSC-759254 | ChEMBL registry synonym — accepted as the source's own label CHEMBL940 ↗ |
| Action | Activate | “gabapentin (Neurontin®) to activate noradrenergic activity” NCT00619983 ↗ |
| Modality | Small molecule | — CHEMBL940 ↗ |
| Route | Oral | “gabapentin 300 mg/day, or gabapentin 900 mg/day by mouth in three divided doses for 8 weeks.” PMID 16139656 ↗ Sep 2005 |